Your search returned 5 results.

Results
	1.	[Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores]. [electronic resource] by Greilsamer, Charlotte Campion, Loïc Cabart, Mathilde Gourmelon, Carole Senellart, Hélène Bennouna, Jaafar Producer: 20181026 In: Bulletin du cancer vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Primary tumors of the lung: should we consider thermal ablation as a valid therapeutic option? [electronic resource] by Palussière, Jean Catena, Vittorio Lagarde, Philippe Cousin, Sophie Cabart, Mathilde Buy, Xavier Chomy, François Producer: 20200527 In: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study. [electronic resource] by Cabart, Mathilde Frénel, Jean-Sébastien Campion, Loïc Ramée, Jean-François Dupuis, Olivier Senellart, Hélène Hiret, Sandrine Douillard, Jean-Yves Bennouna, Jaafar Producer: 20171016 In: Clinical colorectal cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	[KRAS mutation does not influence oxaliplatin or irinotecan efficacy, in association with bevacizumab, in first line treatment of metastatic colorectal cancer]. [electronic resource] by Cabart, Mathilde Frénel, Jean-Sébastien Campion, Loïc Ramée, Jean-François Dupuis, Olivier Senellart, Hélène Hiret, Sandrine Douillard, Jean-Yves Bennouna, Jaafar Producer: 20170125 In: Bulletin du cancer vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib. [electronic resource] by Raimbourg, Judith Joalland, Marie-Pierre Cabart, Mathilde de Plater, Ludmilla Bouquet, Fanny Savina, Ariel Decaudin, Didier Bennouna, Jaafar Vallette, François M Lalier, Lisenn Producer: 20180626 In: Molecular cancer therapeutics vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)